Category: Latest News
-

Generation Income Properties Cuts Q2 Loss 76% as Nasdaq Equity Compliance Is Restored
Generation Income Properties (NASDAQ:GIPR) narrowed its second-quarter 2026 net loss attributable to common shareholders by 76% year over year and regained compliance with Nasdaq’s stockholders’ equity requirement as asset sales, capital raising and preferred equity restructuring strengthened its balance sheet. The Q2 results show measurable progress in GIPR’s deleveraging strategy, but near-term risks remain, including…
-

EyePoint DURAVYU Phase 3 LUGANO Trial Misses Primary Endpoint as Secondary Data Show Reduced Treatment Burden
EyePoint (NASDAQ:EYPT) reported that its Phase 3 LUGANO trial of DURAVYU in wet age-related macular degeneration did not achieve its primary endpoint in the full dataset, although the company reported positive secondary outcomes and an ad hoc analysis in which DURAVYU was non-inferior to aflibercept. The Phase 3 LUGANO trial result puts added importance on…
-

NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp
NEXGEL (NASDAQ:NXGL) reported second-quarter 2026 revenue of $3.69 million and a net loss of $2.87 million as the healthcare products company worked through a slower-than-expected integration and commercial rollout of its newly formed BioNX Surgical division. The Q2 results highlight a transition period following NEXGEL’s April transaction with Celularity, with supply constraints contributing to a…
-

argenx Phase 3 ALKIVIA Trial Meets Primary Endpoint in Autoimmune Myositis
argenx (NASDAQ:ARGX) reported positive topline results from its Phase 3 ALKIVIA trial of VYVGART Hytrulo in adults with autoimmune myositis, with the study meeting its primary endpoint in the combined immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM) population. The Phase 3 ALKIVIA trial produced a statistically significant 15.4-point treatment advantage over placebo in mean Total…
-

IM Cannabis Agrees European Asset Sale as Transaction Targets C$3 Million Equity Improvement
IM Cannabis (NASDAQ:IMCC) has entered into a definitive agreement to sell IMC Holdings and its European-focused assets to Slil.com Holding, a transaction management expects to improve shareholders’ equity by approximately C$3 million while reducing liabilities and simplifying the company’s structure. The proposed European asset sale would leave IM Cannabis focused on its Israeli medical cannabis…
-

Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances
Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq’s stockholders’ equity requirement, with the Nasdaq Hearings Panel granting the company’s request for continued listing subject to certain conditions. The Nasdaq compliance milestone removes one specific listing issue for Glucotrack as management continues its strategic transformation, although the company said it is still working toward full compliance with…
-

HIVE Signs $350 Million AI Cloud Services Agreement as BUZZ HPC Expands Contracted Revenue
HIVE Digital Technologies (NASDAQ:HIVE) has secured a $350 million AI cloud services agreement through its BUZZ HPC subsidiary, adding about $70 million in annualized revenue under a five-year contract with an investment-grade enterprise customer. The deal increases BUZZ HPC’s total annualized revenue to approximately $180 million and commits HIVE to deploying a new 2,016-GPU AI…
-

Harvard reveals $2.2 billion SpaceX holding worth more than half its U.S. equity portfolio
Harvard Management Co. has disclosed a $2.2 billion investment in SpaceX, making the rocket and satellite company by far the largest position in the university endowment’s reported U.S. equity portfolio as of June 30, 2026. According to Harvard’s 13F filing with the Securities and Exchange Commission, the investment comprises approximately 12.94 million SpaceX (Nasdaq: SPCX)…
-

Micron shares rise as White House pushes Apple away from Chinese memory chips
Micron Technology (NASDAQ:MU) shares gained 2.6% ahead of Monday’s opening bell as pressure from the Trump administration on Apple not to source memory chips from Chinese manufacturers strengthened the outlook for U.S. suppliers. Micron stands to benefit directly from Washington’s position. A U.S. Commerce Department block on Apple sourcing DRAM from China’s ChangXin Memory Technologies,…
-

Nvidia to invest $1.5 billion in SB Energy for Ohio AI campus serving OpenAI
Nvidia (NASDAQ:NVDA) has agreed to invest $1.5 billion in SB Energy as part of a major artificial intelligence infrastructure project in Ohio that will provide computing capacity for OpenAI. Under the partnership, Nvidia will become the exclusive provider of AI compute infrastructure at the PORTS-Pike Technology Campus in Pike County. SB Energy will develop, own…